Error: Could not add to watchlist. X

Lion Biotechnologies Inc

+ Watchlist
GNBP:US
Ticker Change
GNBP:US has changed to a new ticker symbol
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Lion Biotechnologies Inc. is engaged in the development and commercialization of a novel autologous cell therapy (ACT) for the treatment of various cancers. The Company also expects to initiate a clinical trial with its lead product candidate, which is an autologous cell therapy using TILs as a second line treatment for Stage IV metastatic melanoma.
ADDRESS
21900 Burbank Blvd.
Third Floor
Woodland Hills, CA 91367
United States
PHONE
1-818-992-3126
  • Elma S Hawkins
    President/CEO
  • Molly Henderson
    Chief Financial Officer
  • Laszlo Radvanyi
    Chief Scientific Officer
  • James G Bender
    VP:Manufacturing
Show More